| PLBI Announces the Acquisition of Regenobody S.A. |
SOSUA BAY, Dominican Republic, Jan. 8, 2010 (GLOBE NEWSWIRE) -- Proton Laboratories, Inc.a Washington corporation, today announced the acquisition of Regenobody S.A., a Dominican Republic company involved in some of the latest technologies associated with stem cell regeneration using the patient's own stem cells. Pursuant to the Agreement, the Company (PLBI) will issue 300,000,000 of its common shares to the Regenobody shareholders, which will result in the shareholders of Regenobody acquiring shareholder control of Proton Laboratories, Inc.
Armando Casciati, newly elected President of Proton Laboratories, Inc. stated that the new company will aggressively work toward completing the development of its laboratory and acquisition of the balance of the needed equipment from its Korean licensor and patent holder, RNLBIO. It is anticipated that a name change and symbol change will occur in the next 90 days. The prior Proton directors have resigned concurrent with the acquisition. More information may be seen at the Company's website www.regenobody.com .
| PROTON LABORATORIES, INC. Stock Symbol :: PLBI |
|
 | PROTON LABORATORIES, INC. (PLBI) Proton Laboratories, Inc., through the acquisition of Regenobody S.A., a Dominican Republic company, is involved in some of the latest technologies associated with stem cell regeneration using the patient's own stem cells. | |||||||||||
Proton Laboratories, Inc. 1135 Atlantic Avenue Alameda, CA 94501 Phone: 888-548-3002 Fax: 888-548-3004 http://www.regenobody.com |
· Stem Cell Therapy International, Inc. is a development-stage company. The Company is engaged in the licensing of stem cell technology, the sale of stem cell products, and the referral of patients to affiliated stem cell clinics through its wholly-owned subsidiary Stem Cell Therapy International Corp. OTCBB:SCII Recent Price: $.112 · International Stem Cell Corporation, incorporated is a biotechnology company. The Company is focused on developing therapeutic products and research products. It is in development-stage. The Company’s objective is to create an unlimited source of human cells for use in the treatment of several diseases, including diabetes, liver disease, corneal disease, and retinal disease through cell transplant therapy.OTCBB: ISCO Recent Price: $.83 |
| Current Projects |
 | Proton Laboratories, Inc. Announces the Acquisition of Regenobody S.A. Proton Laboratories, Inc. has announced the acquisition of Regenobody S.A., a Dominican Republic company involved in some of the latest technologies associated with stem cell regeneration using the patient's own stem cells. Pursuant to the Agreement, the Company (PLBI) will issue 300,000,000 of its common shares to the Regenobody shareholders, which will result in the shareholders of Regenobody acquiring shareholder control of Proton Laboratories, Inc. It is anticipated that a name change and symbol change will occur in the next 90 days. |  |
| Company Overview |
Proton Laboratories, Inc. (OTC.PK: PLBI) REGENOBODY IS A WORLD LEADER IN STEM CELLS TREATMENTS By applying the regenerative powers of stem cells, REGENOBODY AGE REVERSAL achieves the target of halting the ageing degenerative process, improving the quality of life of people willing to maintain a young look and a real rejuvenation in the inside, with better functioning, re-energized and healthy organs. REGENOBODY THERAPEUTIC brings the benefits of bioscience to patients who have been diagnosed with chronic debilitating diseases, offering viable, efficient therapeutic options. Many different conditions can be successfully addressed using their special Stem Cell Therapies. Their institute utilizes the most potent cells in the world, today. Therapies are tailored for each individual, based upon their specific needs. Cells they use are obtained by the most modern technologic method. Their transplant physicians and stem cell laboratory scientists are the most experienced and are regarded as the best in the world. Stem cells derived from Autologous (Stem cells taken from your own body) and Allogeneic (Stem cells from a source other than your own) are used depending on the particular condition that needs to be treated. Patients can rest assured that they will be receiving the most efficacious Stem cell transplant in one of the world's most modern and well equipped facilities. Treatments are delivered by an experienced team of International and U.S. Board Certified Physicians who are guided by strict protocols ensuring excellence in medical care. The journey toward new youth and wellness will begin with begins with the initial phone call and continues throughout treatment at one of their centers. Their Therapeutics and Regenerative Evaluation Centers: • REGENOBODY INSTITUTE, Sosua, Dominican Republic. • HOSPITAL: CENTRO MEDICO DE LA COSTA NORTE Sosua, Dominican Republic • REGENOCLINIX HEALTH INSTITUTE, Sosua, Dominican Republic The Centers are comprised of a complete diagnostic, outpatient facilities, including: · Cardiac Catheterization Lab · Carboxy therapy · Cells quality evaluation · Kelation therapy · Neurotoxins elimination · Oxygen therapy · Peripheral Vascular Ultrasound · Stress testing · Vacuum therapy There the patient undergoes all the necessary pre-treatment tests and protocols that will better his/her general health conditions prior to receiving the stem cell transplant. The "Initial Evaluation" to determine if they would benefit from the treatments, will be given prior to traveling to their facilities after a review of their medical records, conducted by the doctors in conjunction with their personal physician. After the treatment there is usually no need to stay at the hospital/clinic, so patients can choose to stay with family in one of their enchanting hotels: Sosua Bay and Victorian House or in an apartment at their Sosua Paradise "apartments only" Hotel. Stem Cell Therapy Adult Stem Cell Therapy is safe, highly effective and presents minimal risk. It begins with a complete medical evaluation performed by the patient's personal doctor, who will use the necessary documentation sent by them, to determine the patient's overall health and eligibility for therapy. Once qualified, Adult Stem Cells are extracted from the patient's own blood and/or fat, via a standard draw procedure. Since it is the patient's own cells, there is no possibility of the body rejecting its own stem cells. This makes the procedure very safe and non-controversial. The few naturally occurring stem cells are then cultivated into millions of RegenoCells. The RegenoCell are then sent to their Clinics in Sosua and re-injected back into the patient's via an IV or IM injection. There they stimulate tissue re-growth and greater blood flow to the affected areas. Because RegenoCells are extracted from the patient's own body they cannot be rejected by the patient's body. A full report is prepared by the treating physician. Follow-up exams will be handled in the Dominican Republic at their RegenoBody Clinical Center, and all medical information is provided to the patient’s personal physician. The treatment is not a cure, IT IS A PROCESS OF REPAIR, that occurs at varying levels. Repeat treatments may be necessary in certain cases : this will be discussed with the patient before initiating treatment. The RegenoBody Process Once a patient qualifies for treatment, the following steps will apply to easily accompany them throughout the journey to wellness. • They will determine to use the patient’s blood or adipose or Regenobody`s stem cells. Traveling to the Dominican Republic • The patient will land in Puerto Plata’s International airport which is only 5 miles • The patient will be treated at the Regenobody Institute, a full service medical clinic, providing anti-ageing and regenerative treatments to patients of all ages. • After the treatment, the patient will recover at the Sosua Bay Hotel or at the Victorian House Hotel, which are adjacent to the clinics and face the beautiful bay of Sosua. • Rejuvenating and PAD patients will only need 2-3 hours rest to recover. Leadership Armando Casciati, President Jim Wheeler, CEO |
| News |
|
2 comments:
Adult stem cell therapy is set to become a major part of ATS, cancer, hearing loss treatments and of course plastic surgery. The need is however, is to ensure that these are stored in perfect condition before actually getting transplanted to the receiver’s body. This has made the industry of 'controlled rate freezers' to grow at a fast pace to keep up with the demand. I am doing a paper on ‘The Uses of Adult Stem Cell Therapy and the Techniques of Storing Them’ and found your post valuable
For stem cell research we should have more openness in testing and funds availability to the organizations. Stem cell treatments are going play a major role and change way of medical sciences in the near future.
Post a Comment